148 related articles for article (PubMed ID: 33273662)
1. Accumulation of antinuclear associated antibodies in circulating immune complexes is more prominent in SLE patients from Sudan than Sweden.
Elbagir S; Sohrabian A; Elshafie AI; Elagib EM; Mohammed NEA; Nur MAM; Svenungsson E; Gunnarsson I; Rönnelid J
Sci Rep; 2020 Dec; 10(1):21126. PubMed ID: 33273662
[TBL] [Abstract][Full Text] [Related]
2. Sudanese and Swedish patients with systemic lupus erythematosus: immunological and clinical comparisons.
Elbagir S; Elshafie AI; Elagib EM; Mohammed NA; Aledrissy MIE; Sohrabian A; Nur MAM; Svenungsson E; Gunnarsson I; Rönnelid J
Rheumatology (Oxford); 2020 May; 59(5):968-978. PubMed ID: 31411331
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease.
Frodlund M; Wetterö J; Dahle C; Dahlström Ö; Skogh T; Rönnelid J; Sjöwall C
Clin Exp Immunol; 2020 Mar; 199(3):245-254. PubMed ID: 31778219
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE.
Ahlin E; Mathsson L; Eloranta ML; Jonsdottir T; Gunnarsson I; Rönnblom L; Rönnelid J
Lupus; 2012 May; 21(6):586-95. PubMed ID: 22300829
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
[TBL] [Abstract][Full Text] [Related]
6. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden.
Eriksson C; Kokkonen H; Johansson M; Hallmans G; Wadell G; Rantapää-Dahlqvist S
Arthritis Res Ther; 2011 Feb; 13(1):R30. PubMed ID: 21342502
[TBL] [Abstract][Full Text] [Related]
8. Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus.
Hanly JG; Su L; Farewell V; Fritzler MJ
J Immunol Methods; 2010 Jun; 358(1-2):75-80. PubMed ID: 20438730
[TBL] [Abstract][Full Text] [Related]
9. High IgA antiphospholipid autoantibodies in healthy Sudanese explain the increased prevalence among Sudanese compared to Swedish systemic lupus erythematosus patients.
Elbagir S; Elshafie AI; Elagib EM; Mohammed NA; Aledrissy MI; Manivel VA; Pertsinidou E; Nur MA; Gunnarsson I; Svenungsson E; Rönnelid J
Lupus; 2020 Oct; 29(11):1412-1422. PubMed ID: 32741301
[TBL] [Abstract][Full Text] [Related]
10. Antinuclear antibodies measured by enzyme immunoassay in patients with systemic lupus erythematosus: relation to disease activity.
Paz E; Adawi M; Lavi I; Mussel Y; Mader R
Rheumatol Int; 2007 Aug; 27(10):941-5. PubMed ID: 17639400
[TBL] [Abstract][Full Text] [Related]
11. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
Pradhan VD; Patwardhan MM; Ghosh K
Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
[TBL] [Abstract][Full Text] [Related]
12. Anti-nucleosome, anti-chromatin, anti-dsDNA and anti-histone antibody reactivity in systemic lupus erythematosus.
González C; Garcia-Berrocal B; Herráez O; Navajo JA; González-Buitrago JM
Clin Chem Lab Med; 2004 Mar; 42(3):266-72. PubMed ID: 15080558
[TBL] [Abstract][Full Text] [Related]
13. High frequency of Smith autoantibodies in Omani patients with systemic lupus erythematosus.
Al-Jabri AA; Al-Gahdani AK; Al-Shuaili I
Rheumatol Int; 2009 Nov; 30(1):51-6. PubMed ID: 19360411
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and antinuclear antibodies profile among adults with systemic lupus erythematosus and lupus nephritis: a cross-sectional study.
Ahmed N; Shigidi M; Al Agib AN; Abdelrahman H; Taha E
Pan Afr Med J; 2017; 27():114. PubMed ID: 28819535
[TBL] [Abstract][Full Text] [Related]
15. Adipokine interactions promote the pathogenesis of systemic lupus erythematosus.
Chougule D; Nadkar M; Venkataraman K; Rajadhyaksha A; Hase N; Jamale T; Kini S; Khadilkar P; Anand V; Madkaikar M; Pradhan V
Cytokine; 2018 Nov; 111():20-27. PubMed ID: 30098476
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic.
Vlachoyiannopoulos PG; Tzavara V; Dafni U; Spanos E; Moutsopoulos HM
J Rheumatol; 1998 May; 25(5):886-91. PubMed ID: 9598885
[TBL] [Abstract][Full Text] [Related]
17. [Clinical value of multiplex immune assay of antinuclear antibodies in systemic lupus erythematosus.].
Aleksandrova EN; Verizhnikova ZG; Novikov AA; Panafidina TA; Popkova TV; Lukina GV
Klin Lab Diagn; 2018; 63(7):434-438. PubMed ID: 30720960
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases.
Sulcebe G; Morcka K
Clin Exp Rheumatol; 1992; 10(3):255-61. PubMed ID: 1582070
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity.
Emad Y; Gheita T; Darweesh H; Klooster P; Gamal R; Fathi H; El-Shaarawy N; Gamil M; Hawass M; El-Refai RM; Al-Hanafi H; Abd-Ellatif S; Ismail A; Rasker J
Reumatismo; 2018 Jul; 70(2):85-91. PubMed ID: 29976042
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus.
Sohrabian A; Parodis I; Carlströmer-Berthén N; Frodlund M; Jönsen A; Zickert A; Sjöwall C; Bengtsson AA; Gunnarsson I; Rönnelid J
Arthritis Res Ther; 2019 Nov; 21(1):259. PubMed ID: 31783909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
